{"id":"6299a051-291f-4a0b-a278-38a13c2a78cf","modelId":"1aec2bdb-7a3f-4b86-a486-ed3f92674055","versionId":null,"locationId":"19bc0f11-e517-4bd5-bb77-f5a86025c92b","operatorId":null,"ownerId":null,"slug":"neuropace-us-comprehensive-epilepsy-centers","status":"operational","firstSeen":"2013-11-01T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":null,"shiftStructure":null,"hoursPerDay":null,"siteType":null,"operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":null,"deploymentScale":null,"siteEnvironment":null,"operatorType":null,"sourceQualityTier":null,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.neuropace.com/patients/neuropace-rns-system/","name":"NeuroPace","title":"NeuroPace RNS System"}],"notes":"RNS System available at most comprehensive epilepsy centers (CECs) throughout the United States. FDA-approved November 2013 for drug-resistant focal epilepsy. AdventHealth Orlando, University of Miami, and many other hospitals implant patients. First FDA-approved RNS device.","keyFacts":[],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":null,"scaleTier":null,"contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-08-14T13:35:57.394Z","updatedAt":"2026-08-14T13:35:57.773Z","model":{"id":"1aec2bdb-7a3f-4b86-a486-ed3f92674055","companyId":"b553bad1-52b1-4096-b537-da7460d39812","modelName":"RNS System","slug":"neuropace-rns-system","description":"FDA-approved implantable responsive neurostimulation system for focal epilepsy. Continuously monitors and responds to abnormal brain activity.","formFactor":"biometric","industryVertical":"healthcare","environment":"indoor","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.epilepsy.com/stories/fda-approves-responsive-neurostimulation-therapy-neuropace","title":"FDA Approves Responsive Neurostimulation Therapy by NeuroPace","sourceName":"Epilepsy Foundation"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[],"createdAt":"2026-08-08T22:30:24.576Z","updatedAt":"2026-08-09T03:57:34.330Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"b553bad1-52b1-4096-b537-da7460d39812","name":"NeuroPace","slug":"neuropace","description":"NeuroPace (NASDAQ: NPCE) is a Mountain View-based medical device company that developed the [RNS System](/models/rns-system), the only FDA-approved brain-responsive neuromodulation device for treating drug-resistant focal epilepsy. Over 8,000 patients implanted. FY2025 revenue: 00M (25% YoY growth). 230+ Level 4 Comprehensive Epilepsy Centers in the US.","status":null,"founded":null,"hq":"Mountain View, California, USA","hqLat":null,"hqLng":null,"hqGeocodedAt":null,"hqAddress":null,"hqPrecision":null,"website":"neuropace.com","fundingTotal":null,"type":"hardware","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.epilepsy.com/stories/fda-approves-responsive-neurostimulation-therapy-neuropace","title":"FDA Approves Responsive Neurostimulation Therapy by NeuroPace","sourceName":"Epilepsy Foundation"}],"keyFacts":[{"label":"FDA","value":"PMA approved (P100026)"},{"label":"Product","value":"RNS System"},{"label":"Indication","value":"Drug-resistant focal epilepsy (18+)"},{"label":"Type","value":"Closed-loop brain-computer interface"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-08-08T22:30:24.195Z","updatedAt":"2026-08-08T22:41:09.646Z"}},"version":null,"location":{"id":"19bc0f11-e517-4bd5-bb77-f5a86025c92b","name":"United States (comprehensive epilepsy centers nationwide)","slug":"us-epilepsy-centers-nationwide","kind":"hospital","parentLocationId":null,"region":null,"lat":null,"lng":null,"reviewStatus":"reviewed","aliases":[],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-08-14T13:35:57.011Z","updatedAt":"2026-08-14T16:09:25.839Z"},"operator":null,"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/neuropace-us-comprehensive-epilepsy-centers","url":"https://registry.deploy.report/deployments/neuropace-us-comprehensive-epilepsy-centers","name":"RNS System at United States (comprehensive epilepsy centers nationwide)","identifier":"6299a051-291f-4a0b-a278-38a13c2a78cf","startDate":"2013-11-01T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/us-epilepsy-centers-nationwide","name":"United States (comprehensive epilepsy centers nationwide)"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/neuropace","name":"NeuroPace"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/neuropace-rns-system","name":"RNS System"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"commercial","lifecycle_state":"active","architectural_position":{"cohort":"biometric","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}